Peculiarities of the psychological state of pregnant women with HCV infection
DOI:
https://doi.org/10.15574/HW.2024.4(173).4045Keywords:
pregnancy, HCV infection, psychological status, anxiety level (HARS) according to Hamilton, assessment of well-being, activity and mood, quality of lifeAbstract
Aim - to establish the peculiarities of the psychological status of pregnant women with HCV infection in order to prevent their disorders in the pre-pregnancy period.
Materials and methods. A prospective assessment of the psychological status of 100 patients, divided into two groups, was carried out: the Main group (МG) - 60 pregnant women with chronic hepatitis C (HCV infection) in the reactivation phase (with a positive result by the enzyme immunoassay method for anti-HCV), the control group (СG) - 40 healthy pregnant women. Pregnant women were offered to work with questionnaires using the following methods: assessment of parameters of the level of anxiety (HARS) according to Hamilton, assessment of well-being, activity and mood, questionnaire of quality of life SF-36. Statistical processing of research results was carried out using standard programs "Microsoft Excel 5.0" and "Statistica 8.0". Differences at p<0.05 are considered statistically significant.
Results. In the I trimester, pregnant women with HCV infection had an increased level of anxiety (Me (Q1-Q2)) as somatic (4.0 (0.5-6.0) and 0.0 (0.0-1.5), respectively CG; mental (4.0(2.5-6.0) and 1.0 (0.0-2.0), respectively; 0 (0.0-2.0), respectively. In the II trimester, there was a significant difference in total anxiety (10.0 (6.0-15.0) and 6.0 (2.0-11.0), respectively, in pregnant women with HCV infection when compared with healthy pregnant women in all parameters, especially due to the mental component (4.0 (2.0-7.0) and 1.0 (0.0-3.0), respectively. In the III trimester, a high level of differences was found only in the mental component, which on the median was 2 times higher than the level of mental anxiety in pregnant MG (4.0 (1.0-6.0) and 2.0 (0.0-3, 0), respectively; there was a decrease in the total quality of life (46.0 (42.0-51.0) and 52.0 (46.0-56.5), respectively, in all parameters, except for the family assessment (8.0 (6.0-8.0) and 8.0 (7.0-8.0)).
Conclusions. HCV infection during pregnancy is a risk factor for the development of anxiety and is characterized by an increase in the level of anxiety and a decrease in the quality of life throughout pregnancy, especially due to the mental component, which indicates the need to study the relationship between these factors and the frequency of complications during pregnancy, childbirth and postpartum period, as well as the condition of newborns in these women and possible ways of correcting the psychological status to reduce the frequency of obstetric and perinatal complications in the pre-gravid period.
The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was adopted by the Local Moral Committee of the institution indicated in the work. Informed consent was obtained from the women for the study.
No conflict of interests was declared by the author.
References
Adinolfi LE, Nevola R, Lus G et al. (2015). Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol. 21(8): 2269-2280. https://doi.org/10.3748/wjg.v21.i8.2269
Barreira DP, Marinho RT, Bicho M, Fialho R, Ouakinin SRS. (2019). Psychosocial and Neurocognitive Factors Associated With Hepatitis C - Implications for Future Health and Wellbeing. Front Psychol. 9: 2666. Published 2019 Jan 9. https://doi.org/10.3389/fpsyg.2018.02666
Barreira DP, Marinho RT, Bicho M, Flores I, Fialho R, Ouakinin S. (2019). Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects. Front Psychol. 10: 2317. Published 2019 Oct 15. https://doi.org/10.3389/fpsyg.2019.02317
Basch E. (2014). New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annu Rev Med. 65: 307-317. https://doi.org/10.1146/annurev-med-010713-141500
Bertino G, Ragusa R, Corsaro LS et al. (2021). Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2). Health Psychol Res. 8(3): 9450. Published 2021 Jan 20. https://doi.org/10.4081/hpr.2020.9450
Dan AA, Martin LM, Crone C et al. (2006). Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol. 44(3): 491-498. https://doi.org/10.1016/j.jhep.2005.11.046
Fialho R, Pereira M, Gilleece Y, Rusted J, Whale R. (2019). A longitudinal study assessing depression in hepatitis C: Does gender play a role in the new-onset depression during interferon-alpha treatment?. Women Health. 59(2): 181-195. https://doi.org/10.1080/03630242.2018.1449778
Fontana RJ, Hussain KB, Schwartz SM et al. (2002). Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 36: 401-407. https://doi.org/10.1016/S0168-8278(01)00280-X
Hasan I, Putra RP, Yunihastuti E, Kurniawan J. (2022). The Validity and Reliability of the Indonesian Version of the Chronic Liver Disease Questionnaire (CLDQ) in Measuring Quality of Life in Patients with Liver Cirrhosis. Acta Med Indones. 54(1): 10-18.
Heeren A, Bernstein EE, McNally RJ. (2018). Deconstructing trait anxiety: a network perspective. Anxiety Stress Coping. 31(3): 262-276. https://doi.org/10.1080/10615806.2018.1439263
Horváth G, Keleti T, Makara M, Ungvari GS, Gazdag G. (2018). Effect of hepatitis C infection on the quality of life. Perspect Psychiatr Care. 54 (3): 386-390. https://doi.org/10.1111/ppc.12269
Horváth G, Keleti T, Makara M, Ungvari GS, Gazdag G. (2020). Neurocognitive functions in patients with hepatitis C infection. Hepatitis C-fertőzött betegek neurokognitív funkciói. Ideggyogy Sz. 73(1-2): 43-49. https://doi.org/10.18071/isz.73.0043
Kalfoss MH, Reidunsdatter RJ, Klöckner CA, Nilsen M. (2021). Validation of the WHOQOL-Bref: psychometric properties and normative data for the Norwegian general population. Health Qual Life Outcomes. 19(1): 13. https://doi.org/10.1186/s12955-020-01656-x
Kvitka DM, Palamarchuk VO, Zemskov SV, Sichinava RM. (2021). Introduction of the quality of life concept in practical medicine. Clinical Endocrinology and Endocrine Surgery. 1(73): 70-5. https://doi.org/10.30978/CEES-2021-1-70
Lins L, Carvalho FM. (2016). SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 4: 2050312116671725. Published 2016 Oct 4. https://doi.org/10.1177/2050312116671725
Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.
Méndez-Sánchez N, Coronel-Castillo CE, Ramírez-Mejía MM. (2024). Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals. Pathogens. 13(4): 339. Published 2024 Apr 19. https://doi.org/10.3390/pathogens13040339
Prell T, Dirks M, Arvanitis D et al. (2019). Cerebral patterns of neuropsychological disturbances in hepatitis C patients. J Neurovirol. 25(2): 229-238. https://doi.org/10.1007/s13365-018-0709-2
Quelhas R, Lopes A. (2009). Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review. J Psychiatr Pract. 15(4): 262-281. https://doi.org/10.1097/01.pra.0000358313.06858.ea
Rabinowitz J, Williams JBW, Hefting N et al. (2023). Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A). J Affect Disord. 325: 429-436. https://doi.org/10.1016/j.jad.2023.01.029
Stewart BJ, Turnbull D, Mikocka-Walus AA, Harley HA, Andrews JM. (2013). Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C. J Clin Psychol Med Settings. 20(4): 427-439. https://doi.org/10.1007/s10880-012-9339-7
Thompson E. (2015). Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Lond). 65(7): 601. https://doi.org/10.1093/occmed/kqv054
Van der Meulen M, Zamanipoor Najafabadi AH, Lobatto DJ et al. (2020). SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine. 70(1): 123-133. https://doi.org/10.1007/s12020-020-02384-4
WHO QOL. (1995). The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 41(10): 1403-1409. https://doi.org/10.1016/0277-9536(95)00112-K
Zhao TS, Jin C, Wang Y, Cui F. (2021). Knowledge, attitude and psychological status of patients living with hepatitis C in five provinces in China: a cross-sectional survey. BMJ Open. 11(4): e040434. Published 2021 Apr 8. https://doi.org/10.1136/bmjopen-2020-040434
Zhou F, Li J, Lin K, Ji P, Sun Y. (2015). Across-sectional study on anxiety and stress in pregnant women with chronic HBV infection in the People's Republic of China. Neuropsychiatr Dis Treat. 11: 2225-2232. Published 2015 Aug 25. https://doi.org/10.2147/NDT.S88602
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
